Seer Inc (SEER)
1.755
+0.06
(+3.54%)
USD |
NASDAQ |
Apr 18, 16:00
1.755
0.00 (0.00%)
After-Hours: 20:00
Seer Cash from Investing (TTM): 37.90M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 37.90M |
September 30, 2023 | 29.08M |
June 30, 2023 | 36.96M |
March 31, 2023 | -119.16M |
December 31, 2022 | -122.72M |
September 30, 2022 | -207.50M |
June 30, 2022 | -240.87M |
Date | Value |
---|---|
March 31, 2022 | -171.84M |
December 31, 2021 | -170.88M |
September 30, 2021 | -78.12M |
June 30, 2021 | -97.09M |
March 31, 2021 | -25.63M |
December 31, 2020 | -34.56M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-240.87M
Minimum
Jun 2022
37.90M
Maximum
Dec 2023
-89.57M
Average
-97.09M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Candel Therapeutics Inc | -0.28M |
CEL-SCI Corp | -0.3835M |
AIM ImmunoTech Inc | -0.832M |
IGC Pharma Inc | -0.236M |
NovaBay Pharmaceuticals Inc | -0.019M |